Foresite Capital
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
51Deep-tech portfolio30 active
20Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Odyssey Therapeutics
73Co-investorsShare a portfolio company
Portfolio · 51 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Odyssey Therapeutics | Biotech | Active | Dec 4, 2025 | $570.8M |
| Kriya Therapeutics | Biotech | Active | Sep 10, 2025 | $769.5M |
| Spear Bio | Medtech | Active | Aug 5, 2024 | $50.1M |
| Color Health | Medtech | Active | Nov 9, 2021 | $263.5M |
| Frontier Medicines | Biotech | Active | Jul 12, 2021 | $122.0M |
| HealthVerity | Digital health | Active | Jul 7, 2021 | $146.2M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Mammoth Biosciences | Biotech | Active | Aug 23, 2018 | $20.6M |
| DNAnexus | Software | Active | Apr 23, 2015 | $31.6M |
| Abdera Therapeutics | Biotech | Active | — | — |
| Bit Bio | Biotech | Active | — | — |
| Cerevance | Biotech | Active | — | — |
| Chimagen Biosciences | Biotech | Active | — | — |
| Detect | Medtech | Active | — | — |
| Disc Medicine | Biotech | Active | — | — |
| Element Biosciences | Semiconductors | Active | — | — |
| Engrail Therapeutics | Biotech | Active | — | — |
| Evonetix | Biotech | Active | — | — |
| Generate Biomedicines | Biotech | Active | — | — |
| Genomics PLC | Biotech | Active | — | — |
| Identifeye Health | Medtech | Active | — | — |
| Khartis Therapeutics | Biotech | Active | — | — |
| Maze Therapeutics | Biotech | Active | — | — |
| Modal Therapeutics | Biotech | Active | — | — |
| MyOme | Biotech | Active | — | — |
| Nested Therapeutics | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
| Propeller Bio | Biotech | Active | — | — |
| TenSixteen Bio | Biotech | Active | — | — |
| Xaira Therapeutics | Biotech | Active | — | — |
| Eikon Therapeutics | Biotech | Public | Feb 28, 2025 | $1.1B |
| Mythic Therapeutics | Biotech | Closed | Dec 26, 2024 | $53.5M |
| Olema Pharmaceuticals | Biotech | Public | Dec 12, 2024 | $503.5M |
| Seaport Therapeutics | Biotech | Public | Oct 31, 2024 | $225.9M |
| Denali Therapeutics | Biotech | Public | Mar 1, 2024 | $499.7M |
| Hinge Health | Digital health | Public | Dec 28, 2023 | $862.3M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Fate Therapeutics | Biotech | Public | Jul 6, 2020 | $235.8M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Celldex Therapeutics | Biotech | Public | Nov 29, 2016 | $62.5M |
| Syndax Pharmaceuticals | Biotech | Public | Aug 28, 2015 | $139.5M |
| Centessa Pharmaceuticals | Biotech | Acquired | — | — |
| Cytokinetics | Biotech | Public | — | — |
| Korsana Biosciences | Biotech | Public | — | — |
| Morphic Therapeutic | Biotech | Acquired | — | — |
| Pharvaris | Biotech | Public | — | — |
| RayThera | Biotech | Acquired | — | — |
| Tempus AI | Medtech | Public | — | — |
| Verastem Oncology | Biotech | Public | — | — |
| Xenon Pharmaceuticals | Biotech | Public | — | — |
Peer ranks
Portfolio size#7
Portfolio exits#5
Raises, 12 months#22
Co-investors#7
Co-investors
- ARCH VentureVenture capital8 shared
- RA CapitalVenture capital8 shared
- Third Rock VenturesVenture capital5 shared
- Redmile GroupVenture capital4 shared
- Atlas VentureVenture capital3 shared
- Boxer CapitalVenture capital3 shared
- Cormorant Asset ManagementVenture capital3 shared
- F-Prime CapitalVenture capital3 shared
- General CatalystVenture capital3 shared
- GVVenture capital3 shared
Sectors
- Biotech42
- Medtech5
- Digital health2
- Software1
- Semiconductors1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.